These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2691221)

  • 21. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal.
    Ongini E; Caporali MG; Massotti M
    Life Sci; 1985 Dec; 37(24):2327-33. PubMed ID: 3877855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1987 Aug; 39(8):660-1. PubMed ID: 2888862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking.
    Axon DI; Fletcher GH; Starr MS
    Pharmacol Biochem Behav; 1987 Jan; 26(1):45-7. PubMed ID: 3494255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
    Ng GY; George SR
    Eur J Pharmacol; 1994 Nov; 269(3):365-74. PubMed ID: 7895775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
    Klemm WR; Block H
    Pharmacol Biochem Behav; 1988 Feb; 29(2):223-9. PubMed ID: 3283778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
    Bhargava HN; Gulati A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
    Tanimoto K; Tamminga CA; Chase TN
    Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.
    Longoni R; Spina L; Di Chiara G
    Eur J Pharmacol; 1987 Feb; 134(2):163-73. PubMed ID: 2883010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptor subtypes that induce hyperactive urinary bladder response in anesthetized rats.
    Kontani H; Inoue T; Sakai T
    Jpn J Pharmacol; 1990 Dec; 54(4):482-6. PubMed ID: 2087011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
    Dall'Olio R; Gandolfi O; Vaccheri A; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1988; 95(3):381-5. PubMed ID: 2901128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons.
    Ohno Y; Sasa M; Takaori S
    Life Sci; 1987 May; 40(19):1937-45. PubMed ID: 3553819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.
    Molloy AG; O'Boyle KM; Pugh MT; Waddington JL
    Pharmacol Biochem Behav; 1986 Jul; 25(1):249-53. PubMed ID: 3529126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
    Beaulieu M; Felder R; Kebabian JW
    Endocrinology; 1986 Mar; 118(3):1032-9. PubMed ID: 2419116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-1 dopamine receptor stimulation elevates plasma prolactin levels.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Mar; 122(1):139-42. PubMed ID: 3007174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.